UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 35 filers reported holding UNUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $56,000 | – | 23,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 3,361,535 | $14,757,000 | 13.86% |
| New Leaf Venture Partners, L.L.C. | 1,795,545 | $7,882,000 | 2.16% |
| SECTORAL ASSET MANAGEMENT INC | 1,587,437 | $6,969,000 | 0.84% |
| SABBY MANAGEMENT, LLC | 206,358 | $906,000 | 0.44% |
| COWEN INC. | 817,395 | $3,588,000 | 0.38% |
| Novo Holdings A/S | 473,441 | $2,078,000 | 0.31% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 260,595 | $1,144,000 | 0.03% |
| WASATCH ADVISORS LP | 254,449 | $1,117,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 109,075 | $479,000 | 0.01% |
| FIL Ltd | 783,423 | $3,439,000 | 0.01% |